S, B., L, B., A, P., M, W., K, H., S, H., . . . J, C. (2026). Effect of intensive blood pressure and blood glucose control on cardiovascular outcomes driven by reductions in cardiovascular death and nephropathy: Win ratio analysis of ADVANCE trial. European heart journal. Cardiovascular pharmacotherapy, 12(4), 258. https://doi.org/10.1093/ehjcvp/pvag026
Chicago Style (17th ed.) CitationS, Bompoint, Billot L, Patel A, Woodward M, Harris K, Harrap S, Mancia G, Poulter N, and Chalmers J. "Effect of Intensive Blood Pressure and Blood Glucose Control on Cardiovascular Outcomes Driven by Reductions in Cardiovascular Death and Nephropathy: Win Ratio Analysis of ADVANCE Trial." European Heart Journal. Cardiovascular Pharmacotherapy 12, no. 4 (2026): 258. https://doi.org/10.1093/ehjcvp/pvag026.
MLA (9th ed.) CitationS, Bompoint, et al. "Effect of Intensive Blood Pressure and Blood Glucose Control on Cardiovascular Outcomes Driven by Reductions in Cardiovascular Death and Nephropathy: Win Ratio Analysis of ADVANCE Trial." European Heart Journal. Cardiovascular Pharmacotherapy, vol. 12, no. 4, 2026, p. 258, https://doi.org/10.1093/ehjcvp/pvag026.
